Newsquawk Logo

Sarepta Therapeutics (SRPT) reaffirms FY26 sales forecast between USD 1.2-1.4bln; management guides towards lower end of range

ByNewsquawk Staff
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#SAREPTA THERAPEUTICS INC#SRPT.US#FOREX#METALS#EU SESSION#US SESSION#METALS & MINING#DXY#US EQUITIES
Published: Updated:
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.